Novel T790M mutant-selective EGFR kinase inhibitors

被引：0
|
作者：
不详
机构：
来源：
PHARMACOGENOMICS | 2010年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：744 / 744
页数：1
相关论文
共 50 条
  • [31] Intermittent exposure to EGFR tyrosine kinase inhibitors selects less EGFR T790M mutant clones than continuous exposure in lung cancer cell lines
    Lee, Youngjoo
    Kim, Kyoung-Yeon
    CANCER RESEARCH, 2016, 76
  • [32] Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
    Oxnard, Geoffrey R.
    Arcila, Maria E.
    Sima, Camelia S.
    Riely, Gregory J.
    Chmielecki, Juliann
    Kris, Mark G.
    Pao, William
    Ladanyi, Marc
    Miller, Vincent A.
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1616 - 1622
  • [33] Design, synthesis and antitumor activity of novel thiophene-pyrimidine derivatives as EGFR inhibitors overcoming T790M and L858R/T790M mutations
    Xiao, Zhen
    Zhou, Zhihui
    Chu, Cilong
    Zhang, Qian
    Zhou, Lingjia
    Yang, Zunhua
    Li, Xin
    Yu, Liying
    Zheng, Pengwu
    Xu, Shan
    Zhu, Wufu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 203
  • [34] Development of triple mutant T790M/C797S allosteric EGFR inhibitors: a computational approach
    Karnik, Kshipra S.
    Sarkate, Aniket P.
    Lokwani, Deepak K.
    Narula, Ishudeep S.
    Burra, Prasad V. L. S.
    Wakte, Pravin S.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (15): : 5376 - 5398
  • [35] Binding mechanism of kinase inhibitors to EGFR and T790M, L858R and L858R/T790M mutants through structural and energetic analysis
    Bello, Martiniano
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 118 : 1948 - 1962
  • [36] REVERSAL OF RESISTANCE OF EGFR TYROSINE KINASE INHIBITOR (GEFITINIB) BY EGFR T790M SPECIFIC siRNA
    Lee, C-T.
    Park, M-Y.
    Eo, E. Y.
    Lee, J. H.
    ANNALS OF ONCOLOGY, 2013, 24 : 19 - 20
  • [37] Design of a novel covalent EGFR mutant-selective inhibitor
    Sjin, R. Tjin Tham
    Lee, K.
    Sheets, M.
    Martin, T. St.
    Niu, D.
    Chaturvedi, P.
    Westlin, W.
    Petter, R.
    Nacht, M.
    Singh, J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 31 - 31
  • [38] Selective Covalent Targeting of Mutated EGFR(T790M) with Chlorofluoroacetamide-Pyrimidines
    Sato, Mami
    Fuchida, Hirokazu
    Shindo, Naoya
    Kuwata, Keiko
    Tokunaga, Keisuke
    Guo Xiao-Lin
    Inamori, Ryo
    Hosokawa, Keitaro
    Watari, Kosuke
    Shibata, Tomohiro
    Matsunaga, Naoya
    Koyanagi, Satoru
    Ohdo, Shigehiro
    Ono, Mayumi
    Ojida, Akio
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (06): : 1137 - 1144
  • [39] Discovery of selective irreversible inhibitors for EGFR-T790M
    Zhou, Wenjun
    Ercan, Dalia
    Jaenne, Pasi A.
    Gray, Nathanael S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 638 - 643
  • [40] Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors
    De Clercq, Dries J. H.
    Heppner, David E.
    To, Ciric
    Jang, Jaebong
    Park, Eunyoung
    Yun, Cai-Hong
    Mushajiang, Mierzhati
    Shin, Bo Hee
    Gero, Thomas W.
    Scott, David A.
    Janne, Pasi A.
    Eck, Michael J.
    Gray, Nathanael S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (11): : 1549 - 1553
12345